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Tuberculosis in childhood diﬀers from the adult clinical form and even has been suggested that it is a diﬀerent disease due
to its diﬀerential signs. However, prevention, diagnostics, and therapeutic eﬀorts have been biased toward adult clinical care.
Sensibility and speciﬁcity of new diagnostic approaches as GeneXpert, electronic nose (E-nose), infrared spectroscopy, accelerated
mycobacterial growth induced by magnetism, and ﬂow lateral devices in children populations are needed. Adequate and timely
assessment of tuberculosis infection in childhood could diminish epidemiological burden because underdiagnosed pediatric
patientscanevolvetoanactivestateandhavethepotentialtodisseminatetheetiologicalagent Mycobacteriumtuberculosis,notabl y
increasing this worldwide public health problem.
1.Introduction
Tuberculosis is the leading cause of death worldwide, with
over 1.5 million deaths per year. This disease is caused by
Mycobacterium tuberculosis, which is an acid-fast bacilli, and
it is transmitted mainly by the airway [1]. While adult TB
cases are often easily recognizable, due to typical symptoms
(radiological features and a positive sputum smear), TB
in childhood is frequently more diﬃcult to diagnose due
to the atypical radiological features and the diﬃculty to
expectorate[2].Furthermore,thereisasigniﬁcantmorbidity
and mortality in children worldwide [3], with a majority
of cases of latent TB infection (LTBI) and active disease
occurring in developing countries [4]. Childhood tubercu-
losisiscommonlyextrapulmonary,disseminated,andsevere,
especiallyin children under 3 years of age,and it is associated
with high morbidity and mortality [5]. Approximately, 15–
20% of all TB cases in sub-Saharan Africa are in children [6].
The natural history of TB in children and pediatric
patients follows a series of steps. Phase 1 occurred 3–8 weeks
after primary infection. This is the end of incubation period
and the initiation of well-deﬁned signs: fever, erythema
nodosum, a positive tuberculin skin test response, and for-
mation of the primary complex visible on chest radiography.
Phase 2 occurred 1–3 months after the phase 1. In this
period, the bacillus can migrate to other parts of the body
via the blood and represented the period of the highest
risk for the development of tuberculous meningitis and
miliary tuberculosis in young children. This is the phase
where dissemination of the bacillus most frequently occurs.
Phase 3 occurred 3–7 months after primary infection. This
is the period of pleural eﬀusions in >5 years old children
and bronchial disease in <5 years old children. Phase 4
presents after 1–3 years of the phase 1. In this period, the
osteoarticular tuberculosis in children with 5 years or less
appears. Phase 5 occurs up to 3 years after phase 1 and it is
presented after calciﬁcation was completed. Until this phase,
manifestations of classical adult tuberculosis appear [7, 8].
From a tuberculosis control point of view, programs
place an almost exclusive emphasis on adults with sputum2 Journal of Tropical Medicine
smear positive. Tuberculosis in children remains a neglected
area of research despite considerable morbidity and mor-
tality [9–11]. The common perception is that children
rarely develop severe forms of tuberculosis and contribute
little to the maintenance of the tuberculosis epidemic
[12]. Nevertheless, children can transmit Mycobacterium
tuberculosis, this contention is documented in a lot of reports
and community outbreaks. Controversy exists regarding this
fact [13, 14]. Indeed, children do contribute a substantial
proportion of the global tuberculosis disease burden [12],
however, most programs for TB control are limited because
t h e yt a r g e ta n dt r e a to n l ya c t i v ec a s e s[ 15]. Most TB
cases in children present as latent tuberculosis (LTBI) and
active disease occurring mainly in developing countries [4].
Without treatment, the majority of infants aged under 1 year
dies due to TB. Even with eﬀective antimicrobial therapy,
severe TB continues to occur in young children [16].
One interesting issue about the disease in children is that
age determines the progress to disease; infants are at the
highest risk than older children, so it is possible to categorize
allchildrenwith3yearsorlessinhighrisk[17].Otherfactors
can be HIV, malnutrition, measles, and Bordetella pertussis
infection [15]. The aim of the present reviewis to summarize
classicandnewapproachesforthediagnosisofchildhoodTB
and the challenges that this goal represents.
2. Epidemiology and Burden of Disease
The risk of infection depends on the duration of exposure,
the closeness of contact, and the microbial load of the source
case [15, 18]. From 1987 to 1991, the number of TB cases
among children less than 5 years old in the United States
increased by 49% from 674 to 1006 cases. According to the
World Health Organization (WHO) estimations, in 1990,
there were 8 million new cases of TB and 3 million deaths
due to the disease worldwide; 13 million new cases and
450,000 deaths were among children less than 15 years old
[7]. In 1994, it was estimated that the global incidence of
tuberculosis (TB) in children aged 0–14 years would be
more than 1 million cases by 2000, with half of these cases
occurring in Africa. This represents a worldwide increase
of 36% from the 1990 estimate [15]. From the estimated
8.3 million new TB cases diagnosed in 2000, 884,019 cases
(11%) were children, and their contribution to the disease
burden in endemic areas is estimated to be even higher
[4, 17, 19]. Notably, the highest case burden, an estimated
95% of all TB cases, is found in developing countries
[20]. Regional data from the World Health Organization
(WHO) in 2007 showed that smear-positive TB in children
aged <14 years accounted for 0.6–3.6% of reported cases.
However, because ∼95% of cases in children <12 years of
age are smear negative, these data underestimate the true
burden of TB. In 2010, of the ∼1 million estimated cases
of TB in children worldwide, 75% occur in the 22 highest-
burden countries [21]. In a report from a tuberculosis
endemic area in Cape Town, South Africa, children less
than 13 years old contributed 13.7% of the total disease
burden and experienced a tuberculosis incidence rate in
excess of 400/100,000 per year [17]. Although childhood
tuberculosiscontributestoonly3–6%ofthetotalcaseloadin
industrialized countries, it makes up a large proportion (15–
20%) of all TB cases in developing countries [4], moreover,
infectedchildrenareareservoirfromwhichmanyadultcases
will arise [7].
In developing countries, the risk for TB infection and
disease is relatively uniform in the population; annual rates
of infection often exceed 2% depending mainly upon exposi-
tion to infected persons [7]. More recent global and country-
speciﬁc estimates do not stratify these estimates by age, in
part because of the inherent diﬃculties with conﬁrming
the diagnosis of childhood TB [14, 22]. Unfortunately, even
as the TB reports in adults are very common, no recent
epidemiological reports have been published on the global
TB burden in children, this is due to the lack of adequate
diagnostic methods with high precision and sensibility and
the low priority given to children in global TB control pro-
grams [23].
3.DiagnosticDifﬁculties in
Childhood Tuberculosis
The diagnosis of tuberculosis in children is complicated
mainly because (i) TB can mimic many common childhood
diseases, including pneumonia, generalized bacterial and
viral infections, malnutrition, and HIV [18]; (ii) the absence
of a practical reference test or gold standard [12, 24]; (iii) the
inabilityofpreadolescentpatientstoexpectoratesputum[14,
22]; (iv) the nonspeciﬁc clinical presentation [9, 11, 19, 22];
(v) the lower bacillary load often smear negative [3, 14, 19,
22, 25–27]; (vi) conﬁrmation by culture of Mycobacterium
tuberculosis, the gold standard of diagnosis in adult TB,
rarely exceeds 30–40% sensitivity [3] (although it may be
considerably higher in children with advanced disease) [19]
even when using gastric aspirates, induced sputum, liquid
media, and polymerase chain reaction (PCR) [6, 14, 22] and,
in addition, the distinction between recent primary infection
and active disease is highly problematic [28] even the gastric
aspirates continue to be the best specimens for testing for
suspected pulmonary TB in children [29] with 30–40%
sensitivity [19]. Symptoms of childhood TB are nonspeciﬁc,
and up to 50% of children may be asymptomatic in early
stages of the disease. Other aspects like HIV infection
and malnutrition make diﬃcult the diagnosis of childhood
tuberculosis [20]( Table 1).
Most children with TB are classiﬁed as smear-negative
pulmonaryTB(PTB)forthereasonsmentionedabove(diﬃ-
culty to expectorate, lack of equipment to gastric lavage, etc.)
which is an inappropriate term as a smear or culture has not
usually been done. This leads to diﬃculties in determining
the true extent of PTB in children in diﬀerent areas and
circumstances. Extrapulmonary TB (EPTB) accounts for up
to 20–30% of the total caseload of TB in children, and
the diagnosis is usually easier than PTB because of the
characteristic clinical features like lymphadenopathy with
or without scrofula, spinal deformity, disseminated disease,
meningitis, eﬀusions (pleural or pericardial), or painlessJournal of Tropical Medicine 3
Table 1: Clinical similarities and diﬀerences between adult and childhood TB with relevancy to successful diagnosis.
Feature Adults Children
Typical signs Radiological features and a positive
sputum smear
TB can mimic many common childhood diseases.
The clinical symptoms in older children are
cough, fever, wheezing, fatigue, and failure to gain
weight, and in pediatric children are pulmonary
parenchymal disease and intrathoracic
adenopathy, lymphadenopathy, and central
nervous system involvement
X-rays ﬁndings Classical cavitation in lungs
Enlargement of hilar, mediastinal, or subcarinal
lymph nodes and lung parenchymal changes,
hilar lymphadenopathy with or without a focal
parenchymal lesion
TST Cross-reaction with BCG vaccination and exposition with other mycobacteria
Sampling Easy sputum and blood sampling Diﬃculty to expectorate, blood sampling usually
painful in pediatric children
Bacillary load High bacillary load, easy to ﬁnd the
bacillus when technician is skillful
Lower bacillary load and is usually smear negative
even with ﬂuorescent dyes
Bacillus growth in culture High yields of 90–100% Conﬁrmation by culture rarely exceeds 30–40%
Tropism of M. tuberculosis Commonly localized infection in the lungs Commonly extrapulmonary, disseminated
ascite [15]. The isolation of Mycobacterium tuberculosis takes
several weeks. Consequently, the diagnosis of TB in children
is often supported only by epidemiological, clinical, and
radiographic ﬁndings in the presence of a positive tuberculin
skin test [29].
The value of the classic diagnostic is named: (1) exposure
to an adult index case; (2) chronic respiratory symptoms
that do not respond to broad-spectrum antibiotics; (3)
documented weight loss or failure to thrive; (4) a positive
tuberculin skin test (TST); (5) the presence of suggestive
signs on the chest radiograph (CXR), which is greatly
reducedinendemicareaswhereexposuretoand/orinfection
with Mycobacterium tuberculosis is common [12, 14, 15, 21,
22, 24, 30]. These criteria are less helpful in endemic areas
where a positive TST result is common and exposure to
M. tuberculosis is often undocumented [19]( T a b l e s1 and
2). For all these reasons, many children with TB are never
diagnosed or registered as cases of TB [14, 22]. Furthermore,
the consequences of missed diagnosis in children are severe,
as untreated children have a high probability of developing
active TB, usually within two years of infection [31, 32]
(Table 2).
The diﬃculty to obtain samples for TB diagnosis in
children has led researchers to create smart approaches as
“la cuerda dulce” (sweet string), reported by Chow et al. in
2006. They provide a technique which consists of a coiled
nylon string inside a gel capsule. The string unravels through
a hole in the end of the weighted capsule as it descends into
the stomach and the capsule then dissolves in it, allowing
the string to become coated with gastrointestinal secretions
containing whatever pathogens are present. A few hours later
(∼4), the capsule passed in the feces. This methodology is
well tolerated by children and is less invasive than the
gastrointestinal lavage [32].
4.ClassicalDiagnosis
4.1. Clinical Symptoms Approach. The use of well-deﬁned
symptoms improves diagnostic accuracy of PTB [24]. With
clinical symptoms approach only, the status can be classiﬁed
in two, suspected TB or probable TB. Two situations lead the
clinician to suspect that a child has tuberculosis. The ﬁrst
is (a) history of chronic illness with clear symptoms: cough
and/or fever, weight loss or failure to thrive, an inability
to return to normal health after measles or whooping
cough, fatigue, and wheezing; second, (b) one or more of
the following: malnutrition, lymphadenopathy, chest signs,
hepatomegaly and/or splenomegaly, meningeal signs, and/or
ascites. For probable TB, in addition to suspected TB, the
child presents TST positive, suggestive chest radiological
appearances as pleural eﬀusion, caseation of biopsy material,
poor response to 2 weeks antibiotic treatment, and/or
favourable response to antituberculous treatment (weight
gain and loss of signs) [19, 33]. In pediatric TB, the most
commonsymptomsarepulmonaryparenchymaldiseaseand
intrathoracicadenopathyaccountingfor60–80% ofallcases.
Among extrapulmonary manifestations, lymphadenopathy
is the most common (67%), followed by central nervous
system involvement (13%), pleural (6%), miliary and/or dis-
seminated (5%), and skeletal (4%) TB form. Disseminated
(miliary)diseaseandTBmeningitisareusuallyfoundinvery
young children (<3 years-old) and/or HIV-infected children
[21]. TB meningitis occurs when the child has contact with
a suspected or conﬁrmed case. About 50% of childhood TB
cases are discovered in this manner [7].
In general, there is a sense of skepticism regarding the
potential diagnostic value of symptom-based approaches;
however, the natural history of childhood tuberculosis
demonstrates that symptoms may have diagnostic value if4 Journal of Tropical Medicine
Table 2: Pros and cons of most common diagnostic tests for childhood TB.
Methodology Pros Cons
Symptoms No need for lab infrastructure, diagnostic value if
appropriate risk stratiﬁcation is applied
This criterion has been approved only in
conjunction with the TST and suggestive chest
radiography
Traditional chest
radiograph
The basic equipment is very common in hospitals
and some research centers.
The images are not always clear and the lesions
in children are often subjective
Thorax CT scan
Enhanced visualization of small lesions not seen on
chest radiograph. X-ray high-resolution computed
tomography, it is the most sensitive tool currently
available to detect hilar adenopathy and/or early
cavitation can be used for follow-up
Costly; requires scanner which is not readily
available in many settings
Algorithms They are very helpful and easy to use in countries
with restricted technology
Is not commonly used due to lack of
validation, it is based on responses of patients
to which scores are given which are thought to
be very subjective
M. tuberculosis culture Gold standard for deﬁnitive diagnosis of adult TB
Culture usually takes weeks (or four days in
accelerated culture), low sensitivity (50% in
gastric aspirate/sputum)
Smear stain Rapid
Very low sensitivity (50% in gastric
aspirate/sputum), diﬃculty in obtaining
sputum samples, and poor performance of
smear microscopy
Tuberculin skin test (TST) Very common and cheap reagent, easy to use and to
interpret the results
Inespeciﬁc, only indicates infection with a
mycobacteria or prior BCG vaccination
Polymerase Chain Reaction
(PCR)
This is a rapid, sensitive, speciﬁc and aﬀordable
method
These tests are not performed correctly in all
clinical laboratories. The cost involved, the
need for thermocycler (or boiling pots at
speciﬁc temperature), and scrupulous
technique to avoid cross-contamination of
specimens preclude the use of PCR techniques
in many developing countries
In-house nucleic acid
ampliﬁcation assays
Mean sensitivity of 60%, with a proper technique
could be done eﬃciently These assays are dependent of operator’s skill
Adenosin deaminase This method does not require sputum, only blood.
Very high sensitivity and speciﬁcity
The report presents unclear case deﬁnition,
exclusion of nontuberculous patients, and a
relatively small TB patient population (20 with
active TB)
Serology and antigen
detection
In this method, the sample is blood which is easier to
obtain than sputum (in PTB). It is very rapid and
does not require specimen from the site of disease
Sensitivity and speciﬁcity depend on the
antigen used
In vitro interferon-gamma
(IFN-γ) released assays
(IGRAs)
These methods can replace TST for detection of
latent TB infection. Rapid test versions are
inexpensive, and dozens of commercial kits are on
the market; high speciﬁcity (98–100%)
The test may have impaired sensitivity for very
young children, for whom it should not be
used to exclude the presence of M. tuberculosis
GeneXpert MTB/RIF
system
This requires minimal manipulation of sample and
operator training. It utilizes real-time PCR
technology to both diagnose TB and detect
rifampicin resistance. Results in ∼105min.
Only one report in a children population from
South Africa. There is a need to validate in
other populations
Gas sensor array electronic
nose (E-Nose) High speciﬁcity Without data in children populations
appropriateriskstratiﬁcationisapplied.Maraisetal.in2006,
conducted a study to assess the ability to diagnose TB in
HIV-negative children with symptoms and concluded that
PTB can be diagnosed with a reasonable degree of accuracy
in HIV-uninfected children (with a high degree of accuracy
in the low-risk group), using a simple symptom-based
approach. This oﬀers the exciting prospect of improving
access to antituberculosis treatment for children in resource-
limited settings [12].
Houwert et al. in 1998, conducted a prospective evalua-
tionoftheWHOcriteriatoseeifitwasspeciﬁcandpredicted
the situation of TB in children and they conclude thatJournal of Tropical Medicine 5
the diagnosis of tuberculosis must be more seriously consid-
ered when a child presents the triad of the above mentioned
criteria [30]. Marais et al. 2005, evaluated whether well-
deﬁned symptoms have a diagnosis value in children and
a standard symptom-based questionnaire was completed
and reported symptoms were individually characterized. A
tuberculin skin test (TST) and chest radiograph (CXR) were
performed in all children. In this study, well-deﬁned symp-
toms had excellent diagnostic value [34].
4.2. Radiologic Studies. The radiography became available
after the First World War, and since that time, PTB detection
became easier [8]. Evidence of pulmonary TB in chest radi-
ographs varies, but usually radiographs show enlargement
of hilar, mediastinal, or subcarinal lymph nodes and lung
parenchymal changes, hilar lymphadenopathy with or with-
out a focal parenchymal lesion. The most common ﬁndings
are segmental hyperinﬂation then atelectasis, alveolar con-
solidation, interstitial densities, pleural eﬀusion, and, rarely,
a focal mass. Cavitation is rare in young children but is
more common in adolescents, who may develop reactivation
disease similar to that seen in adults [7, 23]. High-resolution
computed tomography is the most sensitive tool currently
available to detect hilar adenopathy and/or early cavitation
[19]( Table 2).
4.3. Algorithms. There are point-scoring systems to make a
diagnostics classiﬁcations. Diagnostic algorithms were devel-
opedtodealwiththesediagnosticdiﬃcultiesandprovidethe
health care worker with a rational, stepwise tool to identify
children in need of TB treatment. They are very helpful and
very easy to use in countries with restricted technology, but a
few of them are used now [6].
4.4. Mycobacterial Detection and Isolation. Microbiological
conﬁrmation of TB in young children is not routinely at-
tempted in many high burden settings due to the diﬃculty
in obtaining samples and the poor performance of smear
microscopy [2]. Diagnosis of TB still relies primarily on
examination of Acid-Fast Bacilli- (AFB-) stained smears
from clinical specimens in adults, however, children with
pulmonary TB usually do not cough up voluntarily, either
because they do not produce sputum or because it produces
discomfort. When sputum samples cannot be obtained, gas-
tric aspirate samples are used for detection and isolation of
M.tuberculosis[35].MostofthecurrentTBdiagnosticmeth-
ods were developed over a century ago. In 1898, Neunier
became the ﬁrst person to culture stomach contents for the
evidenceoftuberculosisinchildren[23,36],soevenwiththis
method, fewer than 20% of children with TB have a positive
AFB smear of sputum or gastric aspirate. For many years, the
collection of three consecutive early morning gastric lavages
or gastric aspirate samples has been the accepted method for
attempting microbiological conﬁrmation even as the yield is
very low and that in many populations cannot be performed
due to the lack of infrastructure. In addition low pH is
well known that kills tuberculous bacilli, indicating that
stomach pH may inhibit TB survival for subsequent culture
[23]. More recently, a number of less invasive alternative
methods have been proposed, including induced sputum
(administration of an inhaled bronchodilator followed by
nebulized hypertonic 3–5% saline and then nasopharyngeal
aspiration or expectoration of mucus from lower respiratory
tract), in the nasopharyngeal aspiration, a cannula elicits a
cough reﬂex and the sweet string test mentioned above [2].
All of these alternative ways of sampling have been made
to increase yield because a positive culture is regarded as
the “gold standard test” to establish a deﬁnitive diagnosis of
TB in a symptomatic child [19]. If culture is negative,
diagnosis is made on the basis of a positive TST, clinical and
radiographicﬁndingssuggestiveofTB,andhistoryofcontact
with an adult source case the child may be diagnosed
with positive TB based on symptomatology. This measure
was taken because the yields in child are less than 50%.
Zar et al. investigate whether sputum induction can be
successfully performed in infants and young children with
and without HIV and determine the utility of salbutamol-
induced sputum compared to gastric lavage (GL) for the
diagnosis of pulmonary tuberculosis. They conclude that
sputum induction can be eﬀectively performed and is well
tolerated and safe even in infants and this induction is better
than GL for the isolation of M. tuberculosis in both HIV-
infected and uninfected infants and children [35].
4.5. Smear Microscopy. Advances have been done in the
performance of smear microscopy for the rapid detection
of MTB, for example, the concentration of specimens by
centrifugation or the change of the staining of carbol
fuchsin (Ziehl-Neelsen or Kinyoun) for a ﬂuorescent dyes
(auramine-rhodamine), which both increases sensitivity and
reduces the time for screening [37]. However, even under
optimal circumstances, the sensitivity of smear microscopy
for the diagnosis of childhood TB remains less than 15%,
except in older children with adult-like disease [2].
4.6. Tuberculin Skin Test (TST). The Tuberculin skin test,
or Mantoux TST, is based on the detection of a cutaneous
delayed-type hypersensitivity response to puriﬁed protein
derivative,apoorlydeﬁnedmixtureofantigenspresentinM.
tuberculosis, Mycobacterium bovis Bacille Calmette-Guerin
(BCG) and several nontuberculous mycobacteria [38]. TST
is the standard method for detecting infection by M. tuber-
culosis.Thereactionismeasuredasmillimetersofinduration
a f t e r4 8t o7 2h o u r s[ 7].This test was the only method avail-
able for the diagnosis of latent tuberculosis infection (LTBI)
until very recently.
With a TST, it is not possible to assert or deny the pres-
ence of TB, but it only indicates infection with a mycobac-
terium. In a child who has not been BCG-vaccinated, a
TST has been deﬁned as positive when the diameter of
skin induration is >10mm, and in a BCG-vaccinated child,
when the diameter of induration is >15mm. A negative
TST does not exclude TB [7] and some induration (5–
14mm) could be supportive if the clinical features and
contact history are suggestive [15]. Furthermore, the utility
of this conventional test is hampered by technical and6 Journal of Tropical Medicine
logistical problems: potential for false-positive and false-
negative results; problems in administration and interpreta-
tion; diﬃculty in separating true infection from the eﬀects
of prior BCG vaccination, infection due to nontuberculous
mycobacteria [4, 26, 39]. In children with debilitating or
immunosuppressiveillnesses,malnutrition,orviral(asHIV)
andcertainbacterialinfections,theyieldisunknown,butitis
certainly higher than 10%. Moreover, false-positive reactions
to TST are often attributed to asymptomatic infection by
environmental nontuberculous mycobacteria [7, 38].
4.7. Polymerase Chain Reaction (PCR). Diagnostic PCR is a
technique of in vitro DNA ampliﬁcation that uses speciﬁc
DNA sequences (oligonucleotides) as eﬀective ﬁshhooks for
theDNA/cDNAofmicroorganisms.Intheory,thistechnique
can detect a single organism in a lot of specimens such as
sputum, gastric aspirate, pleural ﬂuid, cerebrospinal ﬂuid,
blood, and urine. Various PCR assays, most using the
mycobacterial insertion element IS6110 as the DNA marker
for M.tuberculosis-complexorganisms,haveasensitivity and
speciﬁcity greater than 90% for detecting pulmonary TB in
adults [7]( Table 3).
This is a rapid, sensitive, speciﬁc, and reasonable-cost
[11] method for the detection of M. tuberculosis in clinical
samples. The PCR may be used to (a) diagnose tuberculosis
in diﬃcult samples with negative microscopic examination,
negative culture, or with scarce sample; (b) determine if
the organisms in the sample are M. tuberculosis or atypical
mycobacteria; (c) identify the presence of genetic variations
like a mutations or deletions known to be associated with
resistance to some antimycobacterial agents [27].
Studies in children have obtained better sensitivity by
PCR than by culture. In 2001, Gomez-Pastrana et al. [29]
reported a comparison between sensitivity of culture and
PCR showing higher sensitivity for the latter. PCR may
have a special role in the diagnosis of extrapulmonary TB
and pulmonary TB in children since sputum smears are
usually unrevealing in these cases [7]. However, these tests
are not performed correctly in all clinical laboratories. The
cost involved, the need for sophisticated equipment, the
limitations in their speciﬁcity, the need to obtain multiple
samples to optimize yield and scrupulous technique to avoid
cross-contamination of specimens preclude the use of PCR
techniques in many developing countries [11].
Montenegro et al. in 2003, reported a heminested PCR
assay which speciﬁcity was 67%. This was signiﬁcantly
higher than L¨ owenstein-Jensen culture (54%) or AFB stain
(42%) for children with highly probable tuberculosis. PCR
detection rates for culture-positive specimens were 100%
for smear-positive samples and 76.7% for smear-negative
samples. The speciﬁcity of PCR was 100% in control
children. Compared with culture, PCR showed a sensitivity
of 90.4%, a positive predictive value of 89%, a speciﬁcity
of 94%, and a negative predictive value of 95% [11]. In
another research in pulmonary TB, the sensitivity ranges
from 4–80% and the speciﬁcity was 80–100% [27]. In
tubercular mediastinal adenopathy, Gomez-Pastrana et al.
[29] conducted a prospective study comparing nested PCR,
mycobacterial cultures, and the clinical diagnosis to investi-
gate which test had the higher sensitivity and speciﬁcity. The
sensitivity of PCR of gastric lavage/bronchoalveolar lavage
was 56.8% in children with clinically active disease. Authors
conclude that nested PCR is a rapid and sensitive method
for the early diagnosis of TB in children. Additionally, other
unique sequences of M. tuberculosis have been suggested
as diagnostic test for TB, because they are absent in M.
a f r i c a n u m ,M .m i c r o t i ,M .b o v i s ,a n dM. bovis BCG [43].
4.8. In-House Nucleic Acid Ampliﬁcation (NAA) Assays.
These assays are highly dependent of operator’s skills. Perfor-
mance is also inﬂuenced by the choice of target sequence and
DNA extraction method. Interpretation of the performance
of these assays in pediatric TB suspects is confounded
by the lack of a sensitive and speciﬁc reference standard.
When compared with culture, the sensitivity of NAA for
the diagnosis of childhood TB is typically low (40–83%).
However, it appears, at least from some reports, that NAA
identify a group of children who are clinically diagnosed
with TB but in whom mycobacterial culture is negative.
This means that with a proper technique it could be done
eﬃciently [2].
4.9. Adenosine Deaminase. Considering the low yield of
smear and culture in PPTB, nonmicrobiological methods
may provide new tools for diagnosis. Adult studies have
shown increased levels of adenosine deaminase (ADA) in
pleural TB and TB-caused meningitis, both paucibacillary
forms of TB, and have advocated its use in diagnosis. Due
to this evidence, a serum ADA has already been evaluated in
a childhood population with a very high sensitivity (100%)
and speciﬁcity (90.7%) for pulmonary TB. This study
demonstrated the great potential of this technique because
it has signiﬁcant diﬀerence in serum ADA levels between
children with disease and infection. However, there were
several weaknesses in the study design, including unclear
case deﬁnition, exclusion of nontuberculous patients, and
a relatively small TB patient population (20 with active
disease) [23].
In the case of extrapulmonary TB, ADA measurement
can be helpful, but its sensitivity and speciﬁcity varies widely
and has been lower than multiplex PCR using primers for
IS6110, dnaJ, and hsp65 [44]. Speciﬁcally, a meta-analysis
of 63 studies of ADA in tuberculous pleuritis reveals that
the sensitivity of the test is of 0.92 (95% CI 0.90–0.93) and
speciﬁcity of 0.90 (95% CI 0.89–0.91) [45]( Table 3).
4.10. Serology and Antigen Detection. In absence of good
diagnostic method for tuberculosis, the interest in serodi-
agnosis has been increased [27]. Serological tests vary in a
number of features, including antigen composition (38kDa,
Ag 60, and lipoarabinomannan, LAM), antigen source
(native or recombinant), chemical composition (protein or
lipid), extent of antigen(s) puriﬁcation, and immunoglob-
ulin detected. The majority is based on the enzyme-linked
immunosorbent assay (ELISA) rapid versions use variousJournal of Tropical Medicine 7
Table 3: Sensitivity and speciﬁcity of commercial and in-house methods for TB diagnostics.
Methodology Sensitivity Speciﬁcity
Commercial tests
AMTD Standard (n = 15) 0.79 0.91
Smear positive (n = 3) 0.98 0.55
Smear negative (n = 3) 0.75 0.90
Gastric aspirate only (n = 1) 0.73 1.00
Cut-oﬀ: 71,000 (n = 1) 0.83 0.91
Cut-oﬀ: 7,300,000 (n = 1) 0.90 0.85
Cut-oﬀ: 30,000 (n = 1) 0.93 0.66
AMTD Enhanced (n = 5) 0.89 0.98
Smear positive (n = 2) 1.00 0.90
Smear negative (n = 2) 0.83 0.98
Low suspicion of TB (n = 1) 0.83 0.97
Intermediate suspicion of TB (n = 1) 0.75 1.00
High suspicion of TB (n = 1) 0.88 1.00
Amplicor COBAS (n = 10) 0.72 0.99
Low pretest probability (n = 1) 0.33 0.99
Intermediate pretest probability (n = 1) 0.33 0.98
High pretest probability (n = 1) 0.47 1.00
Smear positive (n = 2) 0.91 0.50
Smear negative (n = 3) 0.75 0.99
Amplicor manual (n = 20) 0.68 0.94
Smear positive (n = 6) 0.91 0.74
Smear negative (n = 6) 0.57 0.90
LCx assay (n = 5) 0.90 0.96
Smear positive (n = 2) 0.98 0.10
Smear negative (n = 2) 0.90 0.96
Amplicis Myco B (n = 1) 0.92 0.85
Sputum only (n = 1) 0.91 0.90
GeneXpert adult population (n = 1) 0.95 1.00
Tanzanian adult population (sputum and smear positive, (n = 1) 0.88 0.99
Children population
Two induced sputum samples (n = 1) 0.76 0.99
Smear positive (n = 1) 1.00 0.99
Smear negative (n = 1) 0.61 0.99
In house tests
IS 986 (n = 2) 0.90 0.95
Smear positive (n = 2) 0.97 0.83
Smear negative (n = 2) 0.75 0.47
Sputum only (n = 1) 1.00 1.00
IS 6110 (n = 26) 0.79 0.84
Chemical DNA extraction (n = 1) 0.60 0.92
Simple boiling (n = 1) 0.85 0.98
Smear negative (n = 4) 0.90 0.92
Smear positive (n = 7) 0.92 0.42
Bronchiestasis only (n = 1) NA 0.86
Upper lobe inﬁltrates (n = 1) 0.67 1.00
Agarose gel electrophoresis (n = 1) 0.90 1.00
Dot blot hybridisation (n = 1) 0.92 0.988 Journal of Tropical Medicine
Table 3: Continued.
Methodology Sensitivity Speciﬁcity
ELISA (n = 1) 0.90 1.00
MTP40 (n = 1) 0.97 0.86
MTP40 and αantigen (n = 1) 0.74 1.00
MPB70 (n = 1) 0.98 0.50
Smear positive (n = 1) 0.99 0.13
Smear negative (n = 1) 0.96 0.53
2.4kb DNA (n = 2) 0.55 0.94
65kDa (n = 5) 0.84 0.85
Gastric aspirate only (n = 1) 1.00 0.80
Sputum only (n = 2) 1.00 0.84
MPB64 (n = 2) 0.56 0.84
2.4kb DNA and MBP64 (n = 1) 0.98 0.70
2.4kb DNA and MBP64 and 65-kDa (n = 1) 0.98 0.70
MTB 10 and MTB 11 (n = 1) 0.94 0.94
Ag 85 (n = 1) 0.90 0.94
groEL (n = 1) 0.82 0.81
Meta-analysis for tuberculous pleuritis 0.92 0.90
ADA (n = 63) 0.80 0.84
Pab (n = 1)
E-nose
Culture positive (n = 1) 0.89 0.91
EN Rob (n = 1) 0.68 0.75
EN Walter (n = 1) 0.75 0.67
Values were obtained from the average of diﬀerent studies [40–42]. Most data of sensitivity and speciﬁcity has not been validated for its application in children
populations. AMTD: ampliﬁed Mycobacterium tuberculosis Direct test, LCx: ligase chain reaction, n:n u m b e ro fc o n d u c t e ds t u d i e so ne a c ht e s t ,N A :n o t
available, Pab: protein antigen b.
immunochromatographic formats, with lateral ﬂow being
sthe most popular [31].
Hussey et al. in 1991 [46], used an autoclaved suspension
of M. tuberculosis to detect antibodies in serum from 132
children with clinical pulmonary TB; the test was 62%
sensitive and 98% speciﬁc. Imaz et al. in 2001 [25]r e p o r t e d
the usefulness of the recombinant 16-kDa antigen (re-
Ag16) of Mycobacterium tuberculosis in the serodiagnosis of
tuberculosis (TB) in children measuring the values of IgA,
IgM, and IgG and an increased mean antibody response
t or e A g 1 6w a so b s e r v e di nc o n t a c tc h i l d r e nc o m p a r e dw i t h
nonmycobacterial disease patient with a 95% of speciﬁcity.
A combining result of the IgG and IgA assays led to 43%
positivity in children with active TB. Mycobacterial antigen
detection has been evaluated in adults, but rarely in children
[7].
Serology has found little place in the routine diagnosis
of tuberculosis in children, even though it is rapid and does
not require specimen from the site of disease. Sensitivity
and speciﬁcity depend on the antigen used, gold standard
for the diagnosis of tuberculosis, and the type of tubercular
infection. Though most of these tests have high speciﬁcity,
their sensitivity is poor because several factors can alter the
resultssuchasage,exposuretoothermycobacteria,andBCG
vaccination [27].
4.11. In Vitro Interferon-γ (IFN-γ) Release Assays (IGRAs). A
rapid and accurate tool for diagnosing childhood TB would
be highly beneﬁcial. Much attention has been focused on
immune-based assays that do not rely on sputum but can be
done with blood [31]. This assay is based on the principle
that T-cells of individuals infected with M. tuberculosis
release IFN-γ when they re-encounter TB-speciﬁc antigens
[3]. IGRAs have been developed to replace the tuberculin
skin test (TST) for detection of latent TB infection (LTBI)
[19, 31]. Latest versions of IFN-γ assays use antigens such
as the early secreted antigenic target 6 (ESAT-6) and culture
ﬁltrate protein 10 (CFP-10) [26]. These antigens, encoded
within the region of diﬀerence 1 (RD1) of the M. tuberculosis
genome, are signiﬁcantly more speciﬁc to M. tuberculosis
than PPD, as they are not shared with any BCG vaccine
strains or selected NTM species including M. avium [3, 31].
The commercial tests with this fundament are Quantiferon
TB-gold (QFT-G) and enzyme-linked immunospot assay
(ELISPOT). They are proposed to oﬀer improved speciﬁcity
over the tuberculin skin test (TST) [4].
Dogra et al. in 2007, conducted a study in India in which
he compared the results between the TB-gold Quantiferon
and TST which obtained comparable results even in mal-
nourished children [4]. Furthermore, Nicol et al. in 2005,
reported the speciﬁcity between the PPD and the ELISPOT,Journal of Tropical Medicine 9
theyfoundthatESAT-6-orCFP10-speciﬁcIFN-γ-producing
lymphocytes were detectable at diagnosis in two thirds of
children presenting with a clinical diagnosis of tuberculosis;
however, responses were more frequently positive in patients
with culture-proven disease. Due to this, ELISPOT is a
promisingtoolfortheclinicalevaluationofchildhoodtuber-
culosis [3]. Detjen et al. examined the diagnostic value of
both commercially available IGRAs, compared with the TST,
in the diagnosis of TB. The speciﬁcity for TB of QFT-IT was
100% and the speciﬁcity of T-SPOT was 98%, both of which
were considerably higher than the speciﬁcity of TST. Both
IGRAs showed high diagnostic value in bacteriologically
conﬁrmed childhood TB. Their advantage in this study,
when performed in addition to the TST was the ability to
distinguish positive TST results caused by nontuberculous
mycobacterial disease, thereby reducing overdiagnosis of TB
and guiding clinical management [26].
Bakiretal.in2008,reportedtheprognosticvalueofIFN-
γ as biomarker in children and positive ELISpot results pre-
dict subsequent development of active tuberculosis in recent
tuberculosis contacts, the authors conclude that ELISpot
testing could allow more focused targeting of preventive
therapy to fewer contacts [39]. However, Nicol et al. in 2009,
made a comparison between ELISPOT and the tuberculin
skin test in which some children with active TB resulting
in negative T-SPOT-TB. These suggest that the test may
have impaired sensitivity for very young children, for whom
it should not be used to exclude the possibility of active
tuberculosis [9]. Moreover, signiﬁcantly lower production of
IFN-γ in response to the positive control mitogen phyto-
haemagglutinin was observed in children younger than
4 years old compared with those 4–15 years old children
(P<0.0001) using an in-house ELISA [38].
5.New Approaches inTBDiagnostics
5.1. GeneXpert MTB/RIF System. GeneXpert includes the
development of integrated DNA extraction and ampliﬁca-
tion systems. This requires minimal manipulation of sample
and operator training. It utilizes real-time PCR (rt-PCR)
technology to both diagnose TB and detect rifampicin
resistance. The test ampliﬁes a region of the rpoB gene of
M. tuberculosis. Mutations of this region give rise to 95%
of rifampicin resistance. Resistant strains contain mutations
localized within the 81bp core region of the bacterial RNA
polymerase rpoB gene, which encodes the active site of the
enzyme. In addition, the rpoB core region is ﬂanked by
Mycobacterium tuberculosis-speciﬁc DNA sequences. Thus,
it is possible to test for M. tuberculosis and for rifampicin
resistance simultaneously. The simplicity for the user makes
this an assay that could feasibly be widely implemented
outside centralized laboratories and potentially impacts on
TB control [47]. The Xpert system has some advantages over
the cultivation, mainly in speciﬁcity and a shorter time to get
results [24].
Recently, Nicol et al. in 2011, reported the application of
this method in 452 hospitalized children from South Africa,
with or without HIV, with a median age of 19.4 months,
and suspected of having TB. Two Xpert tests doubled
the case detection rate compared with smear microscopy
(76% versus 38%), identifying all smear-positive and 61%
of smear-negative cases, the speciﬁcity was 98.8%. The
sensitivities for smear-negative TB were 33.3% and 61.1%
when testing one or two samples, respectively. The samplings
were induced sputum and they detected three quarters of
culture-conﬁrmedtuberculosiswithveryhighspeciﬁcity;the
yield of this method was twice that of smear microscopy.
Thiscouldsuggestthepossibilityofreplacingthemicroscopy
for this type of methodology which has greater sensitivity
especially with a second sample [40]( Table 3).
5.2. Gas Sensor Array Electronic Nose (Electronic Nose). The
potential to detect diﬀerent Mycobacterium species in the
headspaces of cultures and sputum samples is another inno-
vative approach that is currently in development. The array
uses 14 sensors to proﬁle a “smell” by assessing the change in
each sensor’s electrical properties when exposed to a speciﬁc
odour mixture. In an initial study using sputum samples
from patients with culture-conﬁrmed tuberculosis and those
without tuberculosis, the E-Nose correctly predicted 89% of
culture-positive patients with a speciﬁcity of 91% [24]. In a
further development applying advanced data extraction and
linear discriminant function analysis, obtained sensitivities
were of 68% and 75%, and speciﬁcities of 75% and 67% for
Rob and Walter electronic noses, respectively [24]. Further
applications of this test, including its potential value in the
diagnosis of child tuberculosis, are needed.
5.3. Other Developments in Progress. Recently, it has been
produced llama (Lama glama) antibodies speciﬁc for the
16kDa Heat Shock Protein of M. tuberculosis, but testing
in patients samples has not been done yet [48]a n da
fast method to diagnose active pulmonary TB by infrared
spectroscopy of serum blood sample seems promissory [49,
50]. Also, a method to accelerate M. tuberculosis growth in
culture applying alternating magnetic ﬁelds frequencies of
8Hz and amplitudes of 80E for 4-5 days was developed
by Noreiko et al., reducing by 7-fold the time in getting
results when compared with traditional culture [51]. With
another relevant development, it is possible to discriminate
among lung diseases as cancer, asthma, and TB by gas
sensor technology, which monitor exhaled volatile organic
compounds directly from breath of patients, and this can be
appliedtodiverseequipmentastheabove-mentionedE-nose
[52].
6. Concluding Remarks
Tuberculosis is the leading cause of death worldwide in both
adults and children, and the incidence and prevalence in
the latter are underestimated due to the diﬃculty to collect
samples and the lack of eﬃcient methods to detect reaction
speciﬁcity with no cross-infection with other mycobacteria.
There are several methods currently being used for TB
diagnosis in children, some classical approaches comprise
mycobacterial culture, microscopy, TST, IGRAs, and more10 Journal of Tropical Medicine
recently high-tech diagnostics approaches as real-time PCR
(GeneXpert), E-nose, and infrared spectroscopy.
After the above mentioned, we can propose the identiﬁ-
cation of mycobacteria in children by two diﬀerent methods.
The ﬁrst would be for use in places where access to
infrastructure and technology is very limited, in this type
of scenario, the best option would be a rapid test based on
lateral ﬂow device to be used in serodiagnosis, that could
be implemented on a test strip to conﬁrm or rule out the
presence of bacilli in the patient. In case of having the
necessary infrastructure, the GeneXpert would be the best
option because it has shown no cross-reactions and also in
studies with children have shown a higher sensitivity and
speciﬁcity than culture methods, but it is clear that a gold
standardforchildhoodtuberculosisisstillneeded,becauseto
date is not possible to be sure about the presence or absence
of the bacillus with a single test in this widely neglected but
relevant epidemiological population.
Regardingthesampletype,todate,inpulmonaryTB,the
sputum induction would be optimal since it is an approach
that does not aﬀect the results (as seen in the capsule as
stomach acids can inhibit the growth of mycobacteria) and
is painless and minimally invasive (unlike gastrointestinal
and nasopharyngeal washings). Speciﬁcally, when sampling
for extrapulmonary TB, blood would be the best option,
however, in patients with systemic TB, mycobacteria have
been found also in the urine, and this kind of sample, the
least invasive to date (not including breath’s patient yet), has
been poorly explored in adult TB, and even less has been
done in children TB research.
Recent developments for TB diagnostics as infrared
spectroscopy (serum) and gas sensor technology (breath or
sputum) seem promissory ﬁelds due to they are fast and
minimally invasive, but their drawbacks are that they must
be validated in diverse populations and improved according
to the patient’s needs. With the above-mentioned ideas, it
is clear that we are starting a 1000-mile walk in childhood
tuberculosis,butsurelythenextgenerationofTBdiagnostics
tools holds great promises.
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